1-4 of 4
José A. Márquez
Close
Sort by
Journal Articles

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Christelle Ferra, María José Terol, Juan Marquet Palomanes, Angel Ramírez Payer, Carol Moreno, Santiago Osorio, Fátima De la Cruz, Jose A. Garcia-Marco, Macarena Ortiz, Eduardo Rios Herranz, Laura Magnano, Sandra Iraheta, Jose Manuel Puerta, Javier de la Serna, Alicia Smucler, Jose Maria Arguiñano, Javier Loscertales, Begoña Muiña, Rubén Fernández, Tomas García, José A. Márquez, Ana Muntañola Prat, Ernesto Perez Persona, Lucrecia Yáñez, Manuel Pérez-Encinas, Marcos González Díaz, Gonzalo Caballero, María Angeles Andreu, Rafael Andreu, Ana Ruiz-Zorrilla, Diana Moreno, Patricia Baltasar
Journal: Blood
Blood (2022) 140 (Supplement 1): 9908–9910.
https://doi.org/10.1182/blood-2022-162186
Published: 2022
Journal Articles

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real -World Setting in Spain: The Venares Study

Patricia Baltasar, María José Terol, Juan Marquet Palomanes, Angel Ramírez Payer, Carol Moreno, Santiago Osorio, Fátima De la Cruz, Jose A. Garcia-Marco, Sr., Macarena Ortiz, Eduardo Ríos Herranz, Laura Magnano, Sandra Iraheta, Jose Manuel Puerta, Javier de la Serna, Alicia Smucler Simonovich, Jose Maria Arguiñano, Javier Loscertales, Begoña Muiña, Ruben Fernandez, Tomas García, José A. Márquez, Ana Muntañola Prat, Ernesto Pérez Persona, Lucrecia Yáñez, Manuel Pérez-Encinas, Marcos González Díaz, Gonzalo Caballero, María Angeles Andreu, Rafael Andreu, Ana Ruiz-Zorrilla, Diana Moreno, Christelle Ferrà
Journal: Blood
Blood (2021) 138 (Supplement 1): 1561.
https://doi.org/10.1182/blood-2021-147685
Published: 2021
Journal Articles

Epidemiological Study and Prognostic Markers in Patients Diagnosed with Chronic Ly Lmphocytic Leukemia. EPIGEN Study.

Mariola Abio, Gonzalo Caballero, Francisco Sala, Guillermina Hurtado, Jose A Marquez, Victoria Dourdil, Susana Arambarri, Filomena Floristan, Nicolas Gonzalez, Roberto Hernandez, Luis Lopez, Luis Perdiguer, Javier Marco, Francisco Sancho, Ignacio Olalla, Pilar Giraldo, MD
Journal: Blood
Blood (2009) 114 (22): 4398.
https://doi.org/10.1182/blood.V114.22.4398.4398
Published: 2009
Journal Articles

GATA2 May Contribute with EVI1 to the Leukemogenic Mechanism in Patients with 3q21q26 Rearrangements.

Iria Vazquez, BSc, Idoya Lahortiga, PhD, Nerea Marcotegui, BSc, Maria Jose Larrayoz, BSc, Carmen Vicente, BSc, Jesus Maria Hernandez, MD, Jose Cervera, MD, Maria Jesus Vidal, MD, Jose A. Marquez, MD, Maria Jose Calasanz, PhD, Maria Dolores Odero, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2852.
https://doi.org/10.1182/blood.V106.11.2852.2852
Published: 2005